These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
630 related articles for article (PubMed ID: 12461076)
1. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076 [TBL] [Abstract][Full Text] [Related]
2. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650 [TBL] [Abstract][Full Text] [Related]
3. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400 [TBL] [Abstract][Full Text] [Related]
4. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963 [TBL] [Abstract][Full Text] [Related]
5. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992 [TBL] [Abstract][Full Text] [Related]
7. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227 [TBL] [Abstract][Full Text] [Related]
8. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors. O'Callaghan CA Microbes Infect; 2000 Apr; 2(4):371-80. PubMed ID: 10817639 [TBL] [Abstract][Full Text] [Related]
9. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572 [TBL] [Abstract][Full Text] [Related]
10. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. Jinushi M; Takehara T; Tatsumi T; Kanto T; Miyagi T; Suzuki T; Kanazawa Y; Hiramatsu N; Hayashi N J Immunol; 2004 Nov; 173(10):6072-81. PubMed ID: 15528343 [TBL] [Abstract][Full Text] [Related]
11. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related]
12. Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis. Wooden SL; Kalb SR; Cotter RJ; Soloski MJ J Immunol; 2005 Aug; 175(3):1383-7. PubMed ID: 16034073 [TBL] [Abstract][Full Text] [Related]
13. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253 [TBL] [Abstract][Full Text] [Related]
14. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182 [TBL] [Abstract][Full Text] [Related]
15. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498 [TBL] [Abstract][Full Text] [Related]
16. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033 [TBL] [Abstract][Full Text] [Related]
17. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. Kaiser BK; Barahmand-Pour F; Paulsene W; Medley S; Geraghty DE; Strong RK J Immunol; 2005 Mar; 174(5):2878-84. PubMed ID: 15728498 [TBL] [Abstract][Full Text] [Related]
18. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021 [TBL] [Abstract][Full Text] [Related]
19. Structure of the murine CD94-NKG2A receptor in complex with Qa-1 MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]